Specialty Pharma: Earnings Better Be Good…or Else

Specialty pharmaceutical companies--think Allergan ( AGN ), Shire ( SHPG ), Valeant Pharmaceuticals International ( VRX ), Teva Pharmaceutical Industries ( TEVA ), and Endo International ( ENDP ), among others--have been outperforming since the start of July but they'll need their earnings to come through for the gains to continue, say Citigroup's Liav Abraham and team. They explain: